Therapeutic RNA company receives additional funding
UK biotech company Transine Therapeutics, which is developing a novel class of therapeutic RNAs, has…
31/05/2022 - 2 minutes
News and Trends
Evotec adds cell therapy manufacturing facility through Rigenerand takeover
German headquartered life science company Evotec SE has acquired 100% of the capital of Rigenerand…
31/05/2022 - 3 minutes
Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments
UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund…
31/05/2022 - 3 minutes
ANGLE and U.S. urology group to undertake prostate cancer study
ANGLE plc has signed a master clinical study agreement with Solaris Health Holdings, LLC and…
31/05/2022 - 5 minutes
Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…
27/05/2022 - 3 minutes
HotSpot looks to boost cancer therapy pipeline with Excelra partnership
U.S. biotech company HotSpot Therapeutics, Inc. is looking to increase its drug development and discovery…
27/05/2022 - 2 minutes
Companies partner on early lung cancer detection blood test
U.S. company CorePath Laboratories is partnering with U.K. diagnostics firm Cizzle Biotechnology on an early-stage…
27/05/2022 - 3 minutes
Blue Lake Biotechnology RSV vaccine gets FDA fast track
U.S. company Blue Lake Biotechnology, Inc. has received U.S. Food and Drug Administration (FDA) Fast…
27/05/2022 - 3 minutes
Animal-free milk company Imagindairy reaches $28M in funding
Israeli foodtech startup Imagindairy, Ltd., developer of animal-free dairy milk proteins, has secured an additional…
27/05/2022 - 4 minutes
Duke Street Bio enters stage with next-generation cancer therapies
The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP…
25/05/2022 - 3 minutes
Vaccines mobilized to control monkeypox outbreak
An unusual outbreak of monkeypox is causing concern worldwide in the shadow of the destructive…
24/05/2022 - 5 minutes
Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
20/05/2022 - 4 minutes
